ABBV Jun 2023 200.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:59AM EST. Market open.
Loading interactive chart…
- Zacks
AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?
AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.
- Simply Wall St.
AbbVie's (NYSE:ABBV) investors will be pleased with their favorable 80% return over the last three years
AbbVie Inc. ( NYSE:ABBV ) shareholders have seen the share price descend 13% over the month. But don't let that...
- Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
In fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV).. Motley Fool contributors Adria Cimino and Keith Speights talk about why these two stocks actually make great buys right now. Adria Cimino (Johnson & Johnson): J&J may have disappointed investors when it reported fourth-quarter earnings on Jan. 24.
© 2023 Yahoo. All rights reserved.
